116 results
Page 2 of 6
8-K
EX-99.1
y3u8u9b
15 Aug 22
Cocrystal Pharma Reports Second Quarter 2022 Financial Results and Provides Updates on its Antiviral Development Programs
8:00am
8-K
EX-99.1
1zs4k2ib
11 May 22
Cocrystal Pharma Reports First Quarter 2022 Financial Results and Provides Updates on its Antiviral Development Programs and Milestones
8:30am
8-K
EX-99.1
3ebcjfn
23 Mar 22
Cocrystal Pharma Reports 2021 Financial Results and Provides Updates on Development Programs and Milestones
4:05pm
8-K
EX-99.1
0ye628s
22 Dec 21
Regulation FD Disclosure
8:30am
8-K
EX-99.1
pe0z82xxhu9jytn
15 Nov 21
Cocrystal Pharma Reports Third Quarter Financial Results and Provides an Update on Development
8:00am
8-K
EX-1.1
m7460a1k3riv2hgz
5 May 21
Entry into a Material Definitive Agreement
5:02pm
8-K
EX-1.1
y1zcgna
27 Aug 20
Entry into a Material Definitive Agreement
5:25pm
424B5
teg 4xhhkd2
27 Aug 20
Prospectus supplement for primary offering
5:24pm
424B5
yrit4bs9r
26 Aug 20
Prospectus supplement for primary offering
5:30pm
8-K
EX-1.1
ja9ihykv82d tz
2 Jul 20
Entry into a Material Definitive Agreement
9:30am
424B5
bbwhtqgq i99zbl5gj
1 Jul 20
Prospectus supplement for primary offering
4:49pm